)
Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.
Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.
Passenger vehicles, two-wheelers and three-wheelers posted double-digit growth in July, while two-wheeler exports rose 27.7 per cent as the auto industry entered the festive season
Divisions over governance, Tata Sons' listing, the SP Group's exit and mounting business losses eroded the consensus behind Chandrasekaran's proposed third term
Tata Sons must constitute a selection committee to choose its next chairman amid governance disputes at Tata Trusts and unresolved questions over listing and the SP Group
While many business groups in India follow a trust structure, experts said it works as long as the promoter, the board and professional management are on the same page
BMW's used-car sales jump 54% in H1; Audi sold nearly one pre-owned car for every new vehicle in 2025; Mercedes-Benz reports double-digit growth
The company is evaluating specialised CROs, data-management and patient-recruitment businesses as it looks to expand across the pharmaceutical value chain
Registrations hit record July high as rainfall recovery, kharif sowing and healthy farm cash flows support rural demand
While several firms have responded with calibrated price increases to protect margins, many signalled that further price escalations could follow
US senate passes bill threatening 100% tariff on top russian oil buyers
No deadline set for policy; non-scheduled drugs account for 82% of market, average channel markup on common dosage forms is 43%
Providers say delayed payments, unexplained claim rejections and below-cost reimbursement for some cancer drugs are straining finances despite recently revised CGHS rates
India's pharma industry must pivot from global leadership in generics to innovation, backed by stronger policy, R&D funding and regulatory reforms, says Satish Reddy
Molbio Diagnostics plans to expand its overseas business through subsidiary OptraScan after the latter secured USFDA clearance, while diversifying beyond tuberculosis-focused public-health revenues.
Audi expects sales to remain broadly flat in 2026 before returning to growth in 2027 as the new models begin contributing
Anand Mahindra says old career templates no longer hold as jobs appear and disappear rapidly
Indian pharma companies are expanding selectively in the US for complex products while retaining India as their manufacturing base despite Trump's tariff threat
The company expects exports to contribute 35 per cent of FY27 revenue as demand improves in North America and Europe, helping absorb newly created manufacturing capacity
Revenue rises 77% YoY; PBIT margin improves 860 bps as XEV 9S drives volumes, EV penetration
Auto and farm profits rise 18%; services PAT jumps 80% on improved performance at MMFSL and Tech Mahindra
Rs 322-crore funding led by Lightrock values Mahindra Last Mile Mobility at Rs 10,822 crore as the company targets a second-half FY27 listing